Evaluation and Risk Factors of Post-traumatic Endophthalmitis
Launched by ASSIUT UNIVERSITY · Nov 2, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand a serious eye condition called post-traumatic endophthalmitis, which can occur after an injury to the eye. The study aims to find out how common this condition is and what factors might increase the risk of developing it. Researchers will also examine the types of bacteria that cause this infection and how it impacts a person's vision and the structure of the eye over time.
To participate in this trial, individuals must have experienced an eye injury that led to post-traumatic endophthalmitis. Anyone who does not wish to join the study will not be included. Once the study begins, participants can expect to undergo evaluations that help the researchers gather important information about their condition. This trial is important because it could lead to better understanding and treatment options for people who suffer from this eye infection after trauma.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients exposed to eye trauma and developed post-traumatic endophthalmitis
- Exclusion Criteria:
- • Patients who refuse to sign informed consent in this study
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported